Viewing SEC Facts Units
Company Name:
PRELUDE THERAPEUTICS INC
CIK:
1678660
Start Filing Date:
2022-07-01
End Filing Date:
2022-09-30
ACCN:
0000950170-22-024732
Value:
$ 47,449,811
Value Error:
$ None
Created By:
Date Filed:
2022-11-14
FY:
2022
Fiscal Period:
Q3
Frame:
CY2021Q3
Type:
us-gaap
Form:
10-Q
Units:
shares